ZSAN
Price:
$0.5576
Market Cap:
$0
Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California. On June 1, 2022, Zosano Pharma Corporation filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.[Read more]
Industry
Biotechnology
IPO Date
2015-01-27
Stock Exchange
NASDAQ
Ticker
ZSAN
According to Zosano Pharma Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is -1564000.00. This represents a change of -102.86% compared to the average of 54.73M of the last 4 quarters.
The mean historical Enterprise Value of Zosano Pharma Corporation over the last ten years is 17.09M. The current -1564000.00 Enterprise Value has changed -1015.26% with respect to the historical average. Over the past ten years (40 quarters), ZSAN's Enterprise Value was at its highest in in the March 2021 quarter at 118.01M. The Enterprise Value was at its lowest in in the March 2015 quarter at -36290177.00.
Average
17.09M
Median
13.81M
Minimum
-4064400.00
Maximum
51.11M
Discovering the peaks and valleys of Zosano Pharma Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 194.48%
Maximum Annual Enterprise Value = 51.11M
Minimum Annual Increase = -535.69%
Minimum Annual Enterprise Value = -4064400.00
Year | Enterprise Value | Change |
---|---|---|
2021 | 51.11M | 194.48% |
2020 | 17.35M | -52.24% |
2019 | 36.34M | 105.22% |
2018 | 17.71M | -535.69% |
2017 | -4064400.00 | 111.26% |
2016 | -1923853.00 | -119.38% |
2015 | 9.93M | -63.57% |
2014 | 27.24M | 165.24% |
2013 | 10.27M | 48.38% |
The current Enterprise Value of Zosano Pharma Corporation (ZSAN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
34.93M
5-year avg
23.69M
10-year avg
17.09M
Zosano Pharma Corporation’s Enterprise Value is
Company | Enterprise Value | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zosano Pharma Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Zosano Pharma Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Zosano Pharma Corporation's Enterprise Value?
What is the highest Enterprise Value for Zosano Pharma Corporation (ZSAN)?
What is the 3-year average Enterprise Value for Zosano Pharma Corporation (ZSAN)?
What is the 5-year average Enterprise Value for Zosano Pharma Corporation (ZSAN)?
How does the current Enterprise Value for Zosano Pharma Corporation (ZSAN) compare to its historical average?